Ticker
VTGNCompany Name
VISTAGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -50.29M | -7784.52% | $ 646K |
3/31/2025 | $ -42.29M | -8701.23% | $ 486K |
12/31/2024 | $ -39.36M | -5637.09% | $ 698.3K |
9/30/2024 | $ -33.65M | -3842.81% | $ 875.7K |
6/30/2024 | $ -28.89M | -2977.55% | $ 970.4K |
3/31/2024 | $ -25.87M | -2431.77% | $ 1.06M |
12/31/2023 | $ -26.12M | -2506.08% | $ 1.04M |
9/30/2023 | $ -31.5M | -3886.37% | $ 810.5K |
6/30/2023 | $ -41.67M | 0% | $ -359.7K |
3/31/2023 | $ -49.93M | 0% | $ -227.3K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for VISTAGEN THERAPEUTICS INC is calculated as follows: FCF [ $ -8.76M ] / Revenues [ $ 334K ]
(=) FCF % [ -2622.93% ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.87% |
median | 7.4% |
std | 19.48% |